APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olaparib

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Olaparib Market Outlook and Growth Opportunities 2026

23 December 2025196 pages

Choose your research edition.

Industry ResearchOlaparib Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Olaparib Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Olaparib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olaparib Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Olaparib Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Olaparib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Olaparib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Olaparib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Olaparib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Olaparib market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Olaparib market include AstraZeneca and Everest Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Olaparib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Olaparib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Olaparib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Olaparib market size, projected growth trends, production technologies, key applications, and end-use industries.

Olaparib Segment by Company

AstraZeneca

Everest Pharmaceuticals

Olaparib Segment by Type

Tablets

Capsules

Olaparib Segment by Application

Ovarian Cancers

Prostate Cancers

Breast Cancers

Others

Olaparib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Olaparib status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Olaparib market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Olaparib significant trends, drivers, influence factors in global and regions.

6. To analyze Olaparib competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olaparib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olaparib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olaparib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Olaparib market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Olaparib industry.

Chapter 3: Detailed analysis of Olaparib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Olaparib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Olaparib in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Olaparib Industry Trends Table 2. Olaparib Industry Drivers Table 3. Olaparib Industry Opportunities and Challenges Table 4. Olaparib Industry Restraints Table 5. Global Olaparib Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Olaparib Revenue Share by Company (2021-2026) Table 7. Global Olaparib Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Olaparib Sales Volume Share by Company (2021-2026) Table 9. Global Olaparib Average Price (US$/pcs) of Company (2021-2026) Table 10. Global Olaparib Company Ranking, (2024-2026) & (USD Million) Table 11. Global Olaparib Key Company Manufacturing Base & Headquarters Table 12. Global Olaparib Company, Product Type & Application Table 13. Global Olaparib Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Olaparib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Capsules Table 19. Global Olaparib Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Olaparib Sales Volume by Type (2021-2026) & (k pcs) Table 21. Global Olaparib Sales Volume by Type (2027-2032) & (k pcs) Table 22. Global Olaparib Sales Volume Share by Type (2021-2026) Table 23. Global Olaparib Sales Volume Share by Type (2027-2032) Table 24. Global Olaparib Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Olaparib Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Olaparib Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Olaparib Sales Value Share by Type (2021-2026) Table 28. Global Olaparib Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Ovarian Cancers Table 30. Significant Companies of Prostate Cancers Table 31. Significant Companies of Breast Cancers Table 32. Significant Companies of Others Table 33. Global Olaparib Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 34. Global Olaparib Sales Volume by Application (2021-2026) & (k pcs) Table 35. Global Olaparib Sales Volume by Application (2027-2032) & (k pcs) Table 36. Global Olaparib Sales Volume Share by Application (2021-2026) Table 37. Global Olaparib Sales Volume Share by Application (2027-2032) Table 38. Global Olaparib Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Olaparib Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Olaparib Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Olaparib Sales Value Share by Application (2021-2026) Table 42. Global Olaparib Sales Value Share by Application (2027-2032) Table 43. Global Olaparib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 44. Global Olaparib Sales by Region (2021-2026) & (k pcs) Table 45. Global Olaparib Sales Market Share by Region (2021-2026) Table 46. Global Olaparib Sales by Region (2027-2032) & (k pcs) Table 47. Global Olaparib Sales Market Share by Region (2027-2032) Table 48. Global Olaparib Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Olaparib Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Olaparib Sales Value Share by Region (2021-2026) Table 51. Global Olaparib Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Olaparib Sales Value Share by Region (2027-2032) Table 53. Global Olaparib Market Average Price (US$/pcs) by Region (2021-2026) Table 54. Global Olaparib Market Average Price (US$/pcs) by Region (2027-2032) Table 55. Global Olaparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 56. Global Olaparib Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Olaparib Sales by Country (2021-2026) & (k pcs) Table 58. Global Olaparib Sales Market Share by Country (2021-2026) Table 59. Global Olaparib Sales by Country (2027-2032) & (k pcs) Table 60. Global Olaparib Sales Market Share by Country (2027-2032) Table 61. Global Olaparib Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Olaparib Sales Value Market Share by Country (2021-2026) Table 63. Global Olaparib Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Olaparib Sales Value Market Share by Country (2027-2032) Table 65. AstraZeneca Company Information Table 66. AstraZeneca Business Overview Table 67. AstraZeneca Olaparib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 68. AstraZeneca Olaparib Product Portfolio Table 69. AstraZeneca Recent Development Table 70. Everest Pharmaceuticals Company Information Table 71. Everest Pharmaceuticals Business Overview Table 72. Everest Pharmaceuticals Olaparib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 73. Everest Pharmaceuticals Olaparib Product Portfolio Table 74. Everest Pharmaceuticals Recent Development Table 75. Key Raw Materials Table 76. Raw Materials Key Suppliers Table 77. Olaparib Distributors List Table 78. Olaparib Customers List Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Olaparib Product Image Figure 2. Global Olaparib Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olaparib Sales Value (2021-2032) & (US$ Million) Figure 4. Global Olaparib Sales (2021-2032) & (k pcs) Figure 5. Global Olaparib Sales Average Price (US$/pcs) & (2021-2032) Figure 6. Global Olaparib Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Global Olaparib Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 12. Global Olaparib Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Olaparib Sales Volume Share by Type (2021-2032) Figure 14. Global Olaparib Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Olaparib Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Olaparib Sales Value Share by Type (2021-2032) Figure 17. Ovarian Cancers Image Figure 18. Prostate Cancers Image Figure 19. Breast Cancers Image Figure 20. Others Image Figure 21. Global Olaparib Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 22. Global Olaparib Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Olaparib Sales Volume Share by Application (2021-2032) Figure 24. Global Olaparib Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Olaparib Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Olaparib Sales Value Share by Application (2021-2032) Figure 27. Global Olaparib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 28. Global Olaparib Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Olaparib Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Olaparib Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Olaparib Sales Value (2021-2032) & (US$ Million) Figure 32. North America Olaparib Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Olaparib Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Olaparib Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Olaparib Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Olaparib Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Olaparib Sales Value (2021-2032) & (US$ Million) Figure 38. South America Olaparib Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Olaparib Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Olaparib Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Olaparib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Olaparib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Olaparib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Olaparib Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Olaparib Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Ovarian Cancers
  • Prostate Cancers
  • Breast Cancers
  • Others
Companies covered
  • AstraZeneca
  • Everest Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Olaparib Sales Value (2021-2032)
  4. 1.2.2 Global Olaparib Sales Volume (2021-2032)
  5. 1.2.3 Global Olaparib Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Olaparib Market Dynamics
  1. 2.1 Olaparib Industry Trends
  2. 2.2 Olaparib Industry Drivers
  3. 2.3 Olaparib Industry Opportunities and Challenges
  4. 2.4 Olaparib Industry Restraints
3 Olaparib Market by Company
  1. 3.1 Global Olaparib Company Revenue Ranking in 2025
  2. 3.2 Global Olaparib Revenue by Company (2021-2026)
  3. 3.3 Global Olaparib Sales Volume by Company (2021-2026)
  4. 3.4 Global Olaparib Average Price by Company (2021-2026)
  5. 3.5 Global Olaparib Company Ranking (2024-2026)
  6. 3.6 Global Olaparib Company Manufacturing Base and Headquarters
  7. 3.7 Global Olaparib Company Product Type and Application
  8. 3.8 Global Olaparib Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Olaparib Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Olaparib Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Olaparib Market by Type
  1. 4.1 Olaparib Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Olaparib Sales Volume by Type
  5. 4.2.1 Global Olaparib Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Olaparib Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Olaparib Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Olaparib Sales Value by Type
  9. 4.3.1 Global Olaparib Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Olaparib Sales Value by Type (2021-2032)
  11. 4.3.3 Global Olaparib Sales Value Share by Type (2021-2032)
5 Olaparib Market by Application
  1. 5.1 Olaparib Application Introduction
  2. 5.1.1 Ovarian Cancers
  3. 5.1.2 Prostate Cancers
  4. 5.1.3 Breast Cancers
  5. 5.1.4 Others
  6. 5.2 Global Olaparib Sales Volume by Application
  7. 5.2.1 Global Olaparib Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Olaparib Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Olaparib Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Olaparib Sales Value by Application
  11. 5.3.1 Global Olaparib Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Olaparib Sales Value by Application (2021-2032)
  13. 5.3.3 Global Olaparib Sales Value Share by Application (2021-2032)
6 Olaparib Regional Sales and Value Analysis
  1. 6.1 Global Olaparib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Olaparib Sales by Region (2021-2032)
  3. 6.2.1 Global Olaparib Sales by Region: 2021-2026
  4. 6.2.2 Global Olaparib Sales by Region (2027-2032)
  5. 6.3 Global Olaparib Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Olaparib Sales Value by Region (2021-2032)
  7. 6.4.1 Global Olaparib Sales Value by Region: 2021-2026
  8. 6.4.2 Global Olaparib Sales Value by Region (2027-2032)
  9. 6.5 Global Olaparib Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Olaparib Sales Value (2021-2032)
  12. 6.6.2 North America Olaparib Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Olaparib Sales Value (2021-2032)
  15. 6.7.2 Europe Olaparib Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Olaparib Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Olaparib Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Olaparib Sales Value (2021-2032)
  21. 6.9.2 South America Olaparib Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Olaparib Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Olaparib Sales Value Share by Country, 2025 VS 2032
7 Olaparib Country-level Sales and Value Analysis
  1. 7.1 Global Olaparib Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Olaparib Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Olaparib Sales by Country (2021-2032)
  4. 7.3.1 Global Olaparib Sales by Country (2021-2026)
  5. 7.3.2 Global Olaparib Sales by Country (2027-2032)
  6. 7.4 Global Olaparib Sales Value by Country (2021-2032)
  7. 7.4.1 Global Olaparib Sales Value by Country (2021-2026)
  8. 7.4.2 Global Olaparib Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Olaparib Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Olaparib Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Olaparib Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Olaparib Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Olaparib Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Olaparib Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Olaparib Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Olaparib Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Olaparib Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Olaparib Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Olaparib Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Olaparib Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Olaparib Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Olaparib Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Olaparib Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Olaparib Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Olaparib Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Olaparib Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Olaparib Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Olaparib Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Olaparib Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Olaparib Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Olaparib Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Olaparib Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Olaparib Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Olaparib Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Olaparib Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Olaparib Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Olaparib Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Olaparib Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Olaparib Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Olaparib Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Olaparib Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Olaparib Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Olaparib Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Olaparib Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Olaparib Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Olaparib Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Olaparib Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Olaparib Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Olaparib Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Olaparib Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Olaparib Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Olaparib Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Olaparib Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Olaparib Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Olaparib Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Olaparib Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Olaparib Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Olaparib Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Olaparib Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Olaparib Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Olaparib Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Olaparib Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Olaparib Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Olaparib Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Olaparib Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Olaparib Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Olaparib Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Olaparib Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Olaparib Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Olaparib Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Olaparib Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Olaparib Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Olaparib Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Olaparib Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Olaparib Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Olaparib Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Olaparib Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Olaparib Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Olaparib Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Olaparib Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Olaparib Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Olaparib Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Olaparib Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Olaparib Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Olaparib Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Olaparib Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Olaparib Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Olaparib Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Olaparib Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Olaparib Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Olaparib Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Olaparib Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Olaparib Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Olaparib Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 Everest Pharmaceuticals
  8. 8.2.1 Everest Pharmaceuticals Company Information
  9. 8.2.2 Everest Pharmaceuticals Business Overview
  10. 8.2.3 Everest Pharmaceuticals Olaparib Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Everest Pharmaceuticals Olaparib Product Portfolio
  12. 8.2.5 Everest Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Olaparib Value Chain Analysis
  2. 9.1.1 Olaparib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Olaparib Sales Mode & Process
  6. 9.2 Olaparib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Olaparib Distributors
  9. 9.2.3 Olaparib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst